Sickle Cell Hemoglobin C Disease: Clinical Trials

1 trial for Sickle Cell Hemoglobin C Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Withdrawn 1

Follow Sickle Cell Hemoglobin C Disease: new trials by email Literature Review of Sickle Cell Hemoglobin C Disease trials Research Report on Sickle Cell Hemoglobin C Disease

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis
MP4CO, Sodium chloride solution - Anemia, Sickle Cell, Sickle Cell Anemia
Phase 2WithdrawnSangart2013-10-012013-10-28

Narrower conditions

Anemia, Sickle Cell (1)  ·  Hemoglobin SC Disease (1)  ·  Vaso-Occlusive Crises (1)

Broader conditions

Anemia (1)  ·  Anemia, Hemolytic (1)  ·  Anemia, Hemolytic, Congenital (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemoglobinopathies (1)

Interventions

PEGylated carboxyhemoglobin bovine (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)

Sponsors

Sangart (1)

Countries

Bahrain (1)  ·  Belgium (1)  ·  Brazil (1)  ·  France (1)  ·  Lebanon (1)  ·  Netherlands (1)  ·  Qatar (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Swee Lay Thein, MD (1)  ·  Tania Small, MD (1)